Biotech
Neuralink
Neuralink raises $650M Series D at $8B valuation
Fremont, CAMay 20, 20251 min read
Total Raised
$650M
Valuation
$8B
Latest Round
Series D
Employees
400+
Neuralink: Series D Funding Round
Neuralink has successfully raised $650M in Series D funding, reaching a valuation of $8B.
Company Overview
Brain-computer interface technology
Funding Details
The Series D round was led by Founders Fund, with participation from DFJ Growth.
Company Information
- Headquarters: Fremont, CA
- Founded: 2016
- Employees: 400+
- Category: Biotech
Investment
Neuralink plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Founders Fund: Verified investor in Series D
- DFJ Growth: Verified investor in Series D
Company Info
Headquarters
Fremont, CA
Founded
2016
Team Size
400+
Last Round
$650M(May 2025)
Investors (2)
F
Founders FundLeadLead Investor
Verified investor in Series D
D
DFJ GrowthInvestor
Verified investor in Series D
Share
Related Reports
Biotech
AusperBio
AusperBio Raises $73M Series B
Biotech company developing AHB-137, an antisense oligonucleotide for chronic hepatitis B treatment entering phase 2 trials
David Chen
Dec 30, 2025
0 min read•$73M Series B
Biotech
Orna Therapeutics
Orna Therapeutics Raises $251M Series B
Biotechnology company developing circular RNA therapeutics for cancer, genetic diseases, and infectious diseases
Emma Rodriguez
Oct 23, 2025
0 min read•$251M Series B
Biotech
Forge Biologics
Forge Biologics Raises $120M Series C
Gene therapy CDMO providing manufacturing and development services for AAV-based genetic medicines
Sarah Kim
Oct 23, 2025
0 min read•$120M Series C
Turn your sales ideas into reality today
Start your 14-day Pro trial today. No credit card required.
Start building for free